OpGen Financial Statements From 2010 to 2024
| OPGNDelisted Stock | USD 1.90 0.15 7.32% |
Check OpGen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OpGen's main balance sheet or income statement drivers, such as , as well as many indicators such as . OpGen financial statements analysis is a perfect complement when working with OpGen Valuation or Volatility modules.
OpGen |
OpGen Inc Company Return On Equity Analysis
OpGen's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current OpGen Return On Equity | -3.15 |
Most of OpGen's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OpGen Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, OpGen Inc has a Return On Equity of -3.1492. This is 86.86% lower than that of the Biotechnology sector and 52.86% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
OpGen Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining OpGen's current stock value. Our valuation model uses many indicators to compare OpGen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OpGen competition to find correlations between indicators driving OpGen's intrinsic value. More Info.OpGen Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value OpGen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for OpGen's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About OpGen Financial Statements
OpGen investors utilize fundamental indicators, such as revenue or net income, to predict how OpGen Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. The company was incorporated in 2001 and is headquartered in Rockville, Maryland. Opgen operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 91 people.
Pair Trading with OpGen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OpGen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OpGen will appreciate offsetting losses from the drop in the long position's value.Moving against OpGen Pink Sheet
| 0.63 | MYO | Myomo Inc | PairCorr |
| 0.62 | ELMD | Electromed | PairCorr |
| 0.56 | BSX | Boston Scientific Corp | PairCorr |
| 0.54 | OM | Outset Medical | PairCorr |
| 0.53 | NXL | Nexalin Technology | PairCorr |
The ability to find closely correlated positions to OpGen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OpGen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OpGen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OpGen Inc to buy it.
The correlation of OpGen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OpGen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OpGen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OpGen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in OpGen Pink Sheet
If you are still planning to invest in OpGen Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OpGen's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |